Alan Riboldi-Tunnicliffe

Dr. Alan Riboldi-Tunnicliffe

ANSTO

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 April 2018 in Journal of Synchrotron Radiation
Verified
Journal Article
Open access
PDF file
DADavid Aragao
David Aragao
JAJun Aishima
Jun Aishima
HCHima Cherukuvada
Hima Cherukuvada
RCRobert Clarken
Robert Clarken
MCMark Clift
Mark Clift
TCThomas Tudor Caradoc-Davies
Thomas Tudor Caradoc-Davies
MX2 is an in-vacuum undulator-based crystallography beamline at the 3 GeV Australian Synchrotron. The beamline delivers hard X-rays in the energy range 4.8–21 keV to a focal spot of 22 × 12 µm FWHM (H × V). At 13 keV the flux at the sample is 3.4 × 1012 photons s−1. The beamline endstation allows robotic handling of cryogenic samplesviaan updated SSRL SAM robot. This beamline is ideal for weakly diffracting hard-to-crystallize proteins, virus particles, protein assemblies and nucleic acids as well as smaller molecules such as inorganic catalysts and organic drug molecules. The beamline is now mature and has enjoyed a full user program for the last nine years. This paper describes the beamline status, plans for its future and some recent scientific highlights.

26 August 2020 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
TKTheresa Klemm
Theresa Klemm
GEGregor Ebert
Gregor Ebert
DCDale J Calleja
Dale J Calleja
CACody C Allison
Cody C Allison
LRLachlan W Richardson
Lachlan W Richardson
DKDavid Komander
David Komander
EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.

3 October 2021 in Cells
Verified
Journal Article
Open access
PDF file
CSChristopher Szeto
Christopher Szeto
ANAndrea Nguyen
Andrea Nguyen
CLChristian A. Lobos
Christian A. Lobos
DCDimitra Chatzileontiadou
Dimitra Chatzileontiadou
DJDhilshan Jayasinghe
Dhilshan Jayasinghe
Stephanie GrasStephanie Gras
Stephanie Gras
The data currently available on how the immune system recognises the SARS-CoV-2 virus is growing rapidly. While there are structures of some SARS-CoV-2 proteins in complex with antibodies, which helps us understand how the immune system is able to recognise this new virus; however, we lack data on how T cells are able to recognise this virus. T cells, especially the cytotoxic CD8+ T cells, are critical for viral recognition and clearance. Here we report the X-ray crystallography structure of a T cell receptor, shared among unrelated individuals (public TCR) in complex with a dominant spike-derived CD8+ T cell epitope (YLQ peptide). We show that YLQ activates a polyfunctional CD8+ T cell response in COVID-19 recovered patients. We detail the molecular basis for the shared TCR gene usage observed in HLA-A*02:01+ individuals, providing an understanding of TCR recognition towards a SARS-CoV-2 epitope. Interestingly, the YLQ peptide conformation did not change upon TCR binding, facilitating the high-affinity interaction observed.

1 February 2021 in iScience
Verified
Journal Article
Open access
CSChristopher Szeto
Christopher Szeto
DCDemetra S.M. Chatzileontiadou
Demetra S.M. Chatzileontiadou
ANAndrea T. Nguyen
Andrea T. Nguyen
HSHannah Sloane
Hannah Sloane
CLChristian A. Lobos
Christian A. Lobos
SGStephanie Gras
Stephanie Gras
CD8+ T cells are crucial for anti-viral immunity, however, understanding T cell responses requires the identification of epitopes presented by Human Leukocyte Antigens (HLA). To date, few SARS-CoV-2-specific CD8+ T cell epitopes have been described. Internal viral proteins are typically more conserved than surface proteins and are often the target of CD8+ T cells. Therefore, we have characterised eight peptides derived from the internal SARS-CoV-2 Nucleocapsid protein predicted to bind HLA-A*02:01, the most common HLA molecule in the global population. We determined not all peptides could form a complex with HLA-A*02:01, and the six crystal structures determined revealed that some peptides adopted a mobile conformation. We therefore provide a molecular understanding of SARS-CoV-2 CD8+ T cell epitopes. Furthermore, we show that there is limited pre-existing CD8+ T cell response towards these epitopes in unexposed individuals. Together, these data show that SARS-CoV-2 Nucleocapsid might not contain potent epitopes restricted to HLA-A*02:01.

23 August 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
CSChristopher Szeto
Christopher Szeto
PZPirooz Zareie
Pirooz Zareie
RWRushika C. Wirasinha
Rushika C. Wirasinha
JZJustin B. Zhang
Justin B. Zhang
ANAndrea T. Nguyen
Andrea T. Nguyen
SDStephen R. Daley
Stephen R. Daley
Interactions between a T cell receptor (TCR) and a peptide-major histocompatibility complex (pMHC) ligand are typically mediated by noncovalent bonds. By studying T cells expressing natural or engineered TCRs, here we describe covalent TCR-pMHC interactions that involve a cysteine-cysteine disulfide bond between the TCR and the peptide. By introducing cysteines into a known TCR-pMHC combination, we demonstrate that disulfide bond formation does not require structural rearrangement of the TCR or the peptide. We further show these disulfide bonds still form even when the initial affinity of the TCR-pMHC interaction is low. Accordingly, TCR-peptide disulfide bonds facilitate T cell activation by pMHC ligands with a wide spectrum of affinities for the TCR. Physiologically, this mechanism induces strong Zap70-dependent TCR signaling, which triggers T cell deletion or agonist selection in the thymus cortex. Covalent TCR-pMHC interactions may thus underlie a physiological T cell activation mechanism that has applications in basic immunology and potentially in immunotherapy.

16 October 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
ASAston Summers
Aston Summers
FZF. Zahra M. Zahir
F. Zahra M. Zahir
GTGemma F. Turner
Gemma F. Turner
MHMoya A. Hay
Moya A. Hay
ARAlan Riboldi-Tunnicliffe
Alan Riboldi-Tunnicliffe
Stephen MoggachStephen Moggach
Stephen Moggach
Molecules that can reversibly switch between electronic states under an external stimulus are of interest to numerous applications. Complexes of open shell metal ions with redox active ligands undergo valence tautomerism, resulting in magnetic, colour and structural switching, relevant to data storage and actuators. However, the precise structural changes occurring during valence tautomerism in the solid state are unclear due to the lack of atomic-resolution characterization. Here, variable temperature and high-pressure single crystal X-ray diffraction is used to characterize valence tautomerism in two isostructural cobalt complexes, [Co(bis(6-methyl-2-pyridylmethyl) amine)(3,5-di-tert-butyl-1,2-dioxolene)]+ and [Co(tris(6-methyl-2-pyridylmethyl)amine)(3,5-di-tert-butyl-1,2-dioxolene)]+ to atomic resolution. The less sterically hindered dimethylated complex exhibits two-step thermally-induced interconversion between the high-spin CoII-seminquinonate and low-spin CoIII-catecholate forms (valence tautomerism) at 155 and 95 K due to the presence of two symmetry-independent complexes. In contrast, the more sterically hindered trimethylated complex does not display thermal valence tautomerism. Both complexes exhibit unique behaviour under high pressure. The dimethylated species undergoes gradual, one-step valence tautomerism in both symmetry-independent complexes concurrently between 0.43 GPa and 1.30 GPa. In the trimethylated species, pressure is sufficient to overcome steric hindrance, leading to one-step valence tautomerism between 2.60 GPa and 3.10 GPa, demonstrating pressure-triggered valence tautomerism in a thermally inactive complex. This study is among the few investigations using in situ high-pressure single crystal X-ray diffraction to achieve atomic-level structural characterization of valence tautomerism, aiding the development of robust structure-property relationships in these types of complexes.